Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06586619 · ClinicalTrials.gov registry record · NA

A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV

A NA study of HIV and Depressive Symptoms, sponsored by Florida International University.

Recruiting
Registry status
NA
Development phase
326
Enrollment target
1
Study location

NCT06586619: Recruiting NA study of HIV and Depressive Symptoms, sponsored by Florida International University.

NCT06586619 is a NA study of HIV and Depressive Symptoms that is actively recruiting participants, run by Florida International University. The registered enrollment target is 326 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06586619, a NA study of HIV and Depressive Symptoms, is actively recruiting participants, sponsored by Florida International University.

RECRUITING
Registry status
NA
Development phase
326 participants
Enrollment target
1
Study location

Study Summary

The goal of this randomized clinical trial is to learn if tai chi/qigong decreases depressive symptoms among older people living with HIV compared to a health education class. The main questions it aims to answer are: Does tai chi/qigong reduce depressive symptoms among older people living with HIV more than a health education class? What are the behavioral, psychological, and biological mechanisms in which tai chi/qigong affects depressive symptoms? Does tai chi/qigong affect depressive symptoms among older people living with HIV differently for men compared to women? Researchers will compare a 12-week, twice a week remotely delivered tai chi/qigong intervention to a health education class of the same duration to determine if it improves depressive symptoms among older people living with HIV. Participants will: Attend either a tai chi/qigong class twice a week for 12 weeks or a health education class of the same duration delivered via Zoom. Each class will be 45-60 minutes in length. Participate in 3 separate interviewer-administered interviews: at the time of enrollment, 3 months after the last class, and 9 months after the last class. Keep a tracking log of their home practice of tai chi/qigong (only participants in the intervention group). Use a biosensor (an earlobe sensor or chest strap) to measure their heart variability. Go to their local lab (e.g., Quest or Labcorp) for blood draw at the time of enrollment and at 9 month post intervention (this will only be a subset of participants).

Primary Outcome

The 10-item Center for Epidemiologic Studies Depression Scale (CES-D) Short form will be used to assess depressive symptoms. Responses refer to the past week and range from: Rarely or none of the time (less than 1 day) = 0 to Most or all of the time (5-7 days) = 3. Scores range from 0-30 with greater scores meaning more depressive symptoms.

Conditions Studied

Interventions

  • BEHAVIORAL Tai chi/qigong intervention group
  • BEHAVIORAL Health Education group

Study Locations (1)

Florida

  • Florida International University - Miami

Trial Details

FieldValue
Enrollment Target 326 participants
Start Date 2025-08-04
Est. Completion 2029-05
Phase NA
Florida International University

89 total trials

What NCT06586619 shows while recruiting

NCT06586619 is an interventional study that assigns participants to a tested intervention. The registered 326 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (26% lower).

The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Tai chi/qigong intervention group is the first listed.

NCT06586619 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06586619 about?

NCT06586619 is a clinical study titled "A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV". The goal of this randomized clinical trial is to learn if tai chi/qigong decreases depressive symptoms among older people living with HIV compared to a health education class. The main questions it aims to answer are: Does tai chi/qigong reduce depressive symptoms among older people living with HIV...

What is the current status of trial NCT06586619?

This trial is currently recruiting. It is a NA study. The enrollment target is 326 participants. The study started on 2025-08-04. Estimated completion is 2029-05.

What conditions does trial NCT06586619 study?

This clinical trial studies the following conditions: HIV, Depressive Symptoms.

What interventions are being tested in trial NCT06586619?

The interventions under investigation include: Tai chi/qigong intervention group (BEHAVIORAL), Health Education group (BEHAVIORAL).

Who is sponsoring clinical trial NCT06586619?

This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06586619 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06586619's enrollment target sits among peer trials

326 64th of 303 higher than 239 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06410144 · 326 participants · NA

    Chronic Kidney Disease-Education (CKD-EDU)

  • NCT07040566 · 326 participants · Phase 2

    A Trial of Varenicline for E-cigarette Cessation

  • NCT07165860 · 326 participants · NA

    Clinical Trial to Reduce Perinatal Intimate Partner Violence

  • NCT04486378 · 327 participants · Phase 2

    A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06586619, the US trial registry maintained by the National Library of Medicine. NCT06586619 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.